EarliTec Diagnostics
EarliTec Diagnostics

EarliTec Diagnostics

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

2019Active38Atlanta, United States

About

EarliTec Diagnostics provides an FDA-cleared, eye-tracking technology system called EarliPoint® that aids qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months to 95 months. The system captures eye gaze data during video observation to analyze visual attention patterns, generating actionable insights on language, cognition, and social engagement to support early detection and track treatment progress. This technology is for clinician use only, helping them provide timely, informed care and communicate outcomes with families. Teams look it up for Healthcare, Autism, Diagnostics.

Frequently asked

What does EarliTec Diagnostics do?

EarliTec Diagnostics is a Healthcare company that offers Platform. Teams look it up for Autism, Diagnostics, HealthTech. It is based in Atlanta, United States and was founded in 2019. Public records show about 38 people and $41M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.

How much funding has EarliTec Diagnostics raised?

EarliTec Diagnostics has raised a total of $41M in funding. The most recent round on record is Series B.

Where is EarliTec Diagnostics headquartered?

EarliTec Diagnostics is headquartered in Atlanta, United States.

When was EarliTec Diagnostics founded?

EarliTec Diagnostics was founded in 2019.

What industry does EarliTec Diagnostics operate in?

EarliTec Diagnostics operates in Healthcare, Autism, Diagnostics, HealthTech, MedTech.

How many employees does EarliTec Diagnostics have?

EarliTec Diagnostics has approximately 38 people on record.

Scores
Measured, not editorial
Ahrefs DR
40/100

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Agent Readiness
47/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
64/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Add first review